Back
TechnipFMC PLC 10K Form
Buy
81
FTI
TechnipFMC PLC
Last Price:
30.82
Seasonality Move:
5.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | FTI/TechnipFMC PLC Quarterly |
2024-02-27 | 10K | FTI/TechnipFMC PLC Annual |
2023-10-26 | 10Q | FTI/TechnipFMC PLC Quarterly |
2023-07-27 | 10Q | FTI/TechnipFMC PLC Quarterly |
2023-04-27 | 10Q | FTI/TechnipFMC PLC Quarterly |
2023-02-24 | 10K | FTI/TechnipFMC PLC Annual |
Receive FTI News And Ratings
See the #1 stock for the next 7 days that we like better than FTI
FTI Financial Statistics
Sales & Book Value
Annual Sales: | $7.82B |
---|---|
Cash Flow: | $225.3M |
Price / Cash Flow: | 15.98 |
Annual Sales: | $7.66 |
Price / Book: | 4.02 |
Profitability
EPS (TTM): | 1.52000 |
---|---|
Net Income (TTM): | $671.2M |
Gross Margin: | $1.27B |
Return on Equity: | 21.46% |
Return on Assets: | 7.11% |
TechnipFMC PLC Earnings Forecast
Key TechnipFMC PLC Financial Ratios
- The Gross Profit Margin over the past 25 years for FTI is 16.28%.
- The Selling, General & Administrative Expenses for FTI have been equal to 8.64% of Gross Profit Margin.
- The Research & Development expenses have been 0.88% of Revenue.
- The Interest Expense is 217.44% of Operating Income.
- The Net Earning history of FTI is 0.72% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 13 years.
TechnipFMC PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | FTI |
CUSIP: | G87110 |
Website: | technipfmc.com |
Debt
Debt-to-Equity Ratio: | 0.3 |
---|---|
Current Ratio: | 1.14 |
Quick Ratio: | 0.8 |
Price-to-Earnings
Trailing P/E Ratio: | 256.92 |
---|---|
Forward P/E Ratio: | 15.37 |
FTI Technical Analysis vs Fundamental Analysis
Buy
81
TechnipFMC PLC (FTI)
is a Buy
Is TechnipFMC PLC a Buy or a Sell?
-
TechnipFMC PLC stock is rated a Buy
The current TechnipFMC PLC [FTI] share price is $30.83. The Score for FTI is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.